尽量减少COPD的吸入性皮质类固醇
Benji Heran1, Thomas L Perry, Ken Bassett
1Department of Anaesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver. bsheran@mail.ubc.ca.
African journal of primary health care & family medicine
|January 23, 2025
概括
吸入性皮质类固醇 (ICS) 对慢性阻塞性肺部疾病 (COPD) 提供有限的益处,并带有风险. 现在的指导方针建议将ICS限制在严重的COPD病例中,频繁恶化.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 吸入性皮质类固醇 (ICS) 用于慢性阻塞性肺病 (COPD) 症状管理.
- 随机试验显示ICS对COPD死亡率和生活质量的影响有限.
- 在COPD中使用ICS与潜在的严重危害有关.
研究的目的:
- 审查吸入性皮质类固醇 (ICS) 治疗慢性阻塞性肺病 (COPD) 的证据.
- 为了评估ICS治疗COPD患者的益处与风险.
- 提供有关适当的ICS使用和COPD下药的指导.
主要方法:
- 随机试验和临床指导方针对COPD的ICS进行审查.
- 对益处 (症状,恶化) 与危害 (肺炎,骨折) 的分析.
- 考虑患者因素,如COPD的严重程度和恶化的频率.
主要成果:
- 在COPD症状和恶化方面,ICS提供了有限的益处.
- 长期使用ICS会增加严重不良事件的风险,如肺炎和骨折.
- 指导方针建议将ICS限制在严重的COPD,并频繁恶化.
结论:
- 在轻度的COPD中,ICS的风险往往超过了益处.
- 停止处方ICS是安全的稳定患者不常见的恶化.
- 最初的COPD治疗应该优先考虑支气管扩展剂而不是ICS.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
176
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
176
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
Inhaled Medications
236
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
236
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


